| RS2046937845 |
NOTCH3
|
Health Risk |
Pathogenic |
NOTCH3-related disorder, NOTCH3-related disorder |
| RS2046947920 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2046948026 |
FLCN
|
Health Risk |
Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2046950183 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2046952880 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2046996113 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive inherited pseudoxanthoma elasticum, Pseudoxanthoma elasticum |
| RS2046997344 |
ABCC6
|
Health Risk |
Pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS2047000316 |
ABCC6
|
Health Risk |
Likely pathogenic |
Arterial calcification, generalized |
| RS2047006361 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047007301 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS2047007480 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2047011004 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2047013877 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2047014823 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047017160 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2047052213 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2047058557 |
LOC126806423;TTN;TTN-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS2047085522 |
LOC126806423;TTN;TTN-AS1
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2047088558 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2047092163 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047092959 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial spontaneous pneumothorax, Birt-Hogg-Dube syndrome |
| RS2047096127 |
TCF4
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2047099006 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2047103931 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2047106597 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2047107163 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2047109965 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2047119736 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Inborn genetic diseases |
| RS2047122054 |
MUC16
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2047122813 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, FLCN-related disorder |
| RS2047123162 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047128609 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2047135088 |
CEP164
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2047172274 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047175695 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047176639 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2047177327 |
THOC2
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-short stature-overweight syndrome, X-linked intellectual disability-short stature-overweight syndrome |
| RS2047178513 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047181267 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2047236705 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2047242821 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2047248214 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047264129 |
TANGO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2047280731 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2047298129 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome, Orofaciodigital syndrome I |
| RS2047299277 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome 10, Joubert syndrome 10 |
| RS2047302808 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS2047310284 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS2047316806 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome 1 |
| RS2047317144 |
C5
|
Health Risk |
Pathogenic |
— |
| RS2047318775 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome, Orofaciodigital syndrome I |
| RS2047328405 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
11 conditions, Autosomal dominant distal renal tubular acidosis |
| RS2047337144 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2047357659 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2047358814 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant distal renal tubular acidosis, Renal tubular acidosis |
| RS2047371081 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2047380262 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2047381754 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2047398183 |
SLC4A1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS2047400320 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2047400808 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2047401561 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2047401850 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant distal renal tubular acidosis, Autosomal dominant distal renal tubular acidosis |
| RS2047402332 |
ARHGEF9
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 8 |
| RS2047402577 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2047407019 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryohydrocytosis, Cryohydrocytosis |
| RS2047417339 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2047420220 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2047426908 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2047435382 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2047444948 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2047467477 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2047469522 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2047487518 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2047490848 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2047492649 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2047492720 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2047513887 |
ABCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2047514376 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2047516641 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2047523428 |
BRD4
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 6, Cornelia de Lange syndrome 6 |
| RS2047525622 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2047560187 |
BRD4
|
Health Risk |
Pathogenic |
— |
| RS2047653801 |
CFAP410
|
Health Risk |
Pathogenic |
— |
| RS2047658370 |
CFAP410
|
Health Risk |
Pathogenic |
— |
| RS2047659273 |
FGF14
|
Health Risk |
Pathogenic |
Cerebellar ataxia, Spinocerebellar ataxia 27B |
| RS2047665750 |
THOC2
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-short stature-overweight syndrome, X-linked intellectual disability-short stature-overweight syndrome |
| RS2047676193 |
ABCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2047686121 |
CFAP410
|
Health Risk |
Pathogenic |
— |
| RS2047687010 |
CFAP410
|
Health Risk |
Pathogenic |
Retinal dystrophy with or without macular staphyloma, Retinal dystrophy with or without macular staphyloma |
| RS2047717398 |
KIF1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS2047724604 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS2047742790 |
ABCC6
|
Health Risk |
Pathogenic |
— |
| RS2047743679 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Hypertrophic cardiomyopathy 9 |
| RS2047747647 |
OFD1
|
Health Risk |
Pathogenic |
Simpson-Golabi-Behmel syndrome type 2, Simpson-Golabi-Behmel syndrome type 2 |
| RS2047765952 |
OFD1
|
Health Risk |
Likely pathogenic |
— |
| RS2047770566 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS2047770974 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS2047780556 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2047794498 |
KIF3B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 89, Retinitis pigmentosa 89 |